BIOTECHNOLOGY

11th Berlin Conference on Life Sciences: Novel antimicrobials and AMR diagnostics

Scritto da CYBERMED NEWS
facebook Share on Facebook

02.03.2018

Over it’s ten year’s history, the Berlin Conference has become a must-attend event for Life Science decision makers, business developers, investors and legal experts.
The 11th conference will explore the exciting market for the development of novel antimicrobials and AMR diagnostics.


    Antimicrobial Market – Industry overview, SME engagement & financial insights
    Technology Perspective – New approaches to efficiently combat antimicrobial resistance
    Diagnostic Challenge – Promising molecular methods of detecting multiple drug resistance
    Legal Environment & Reimbursement – The challenges of bringing antimicrobials to the market
    R&D Trends – Research and development beyond antibiotics & public-private partnerships
    Start-up Pitch – Investor talk & new business models in the field of therapeutics and diagnostics

 

https://european-biotechnology.com/events/highlights/highlight/11th-berlin-conference-on-life-sciences-novel-antimicrobials-and-amr-diagnostics.html


Related Articles